Golden
Sands Capital Ventures

Sands Capital Ventures

A venture capital and private equity firm investing in technology, healthcare, financial services, and consumer sectors.

Sands Capital Ventures, an affiliate of Sands Capital Management, is a venture capital and private equity firm investing in technology, healthcare, financial services, and consumer sectors that is headquartered in Arlington, Virginia and was founded in 1992 by Frank M. Sands Jr and Michael Rubin. The firm uses six investment criteria to guide how it makes investments, these criteria are: sustainable above-average growth, leadership in a promising business space, significant competitive advantage, clear mission and value-added focus, financial strength, and rational valuation and terms. Notable investments made by Sands Capital Ventures include: Acessa Health, Mulesoft, Paydiant, DocuSign, Funding Circle, Teckro, Health Catalyst, Upgrade Lending Club, and WireWheel. 

Investment funds

Sands Capital Private Growth Fund II

On April 29, 2016 Sands Capital Ventures announced raising $75 million for their Sands Capital Private Growth Fund II. Capital for the Sands Capital Private Growth Fund II came from at least 41 limited partners. 

Timeline

Funded Companies

21 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

DataRobot sells a machine learning platform that helps users build and deploy accurate predictive models. The Boston-based company was founded in 2012 by Jeremy Achin.

A healthcare technology company offering a platform for organizing healthcare data from multiple systems.

Scopely is a Los Angeles-based company founded by Walter Driver.

Day Zero Diagnostics is a company founded by Miriam Huntley.

UPGRADED is a sport company founded by Sandy Khaund.

NanoView Biosciences is a Boston-based life science company.

Avitide is a Lebanon, New Hampshire-based company.

A platform-technology company offering gene-expression profiling solutions for pharmaceutical discovery

A life sciences company that has developed and commercialized a dna sequencing platform for human genome sequencing and analysis

A company developing and offering open platform for industrial, academic and clinical scientists to develop and use multiplexed biological assays

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References